Genetics - Doctors Revision

Sociology and Anthropology, Genetics, Uncategorized

The Genetic Code and Gene Regulation: How Cells Read, Control and Use DNA

doctorsrevision@gmail.com / September 22, 2026

Core idea The genetic code is the rule that maps nucleotide triplets in mRNA to amino acids. Gene regulation determines which genes are transcribed, in which cells, at what time and at what level. The same genome can therefore produce neurons, hepatocytes and lymphocytes with different functions. Learning outcomes Use codons and reading frames correctly; explain initiation, elongation and termination; describe promoter, enhancer, silencer and epigenetic control; compare prokaryotic operons with eukaryotic regulation; and connect regulatory failure to disease, cancer and treatment. 1. The genetic code Messenger RNA is read in groups of three nucleotides called codons. There are 64 codons: 61 specify amino acids and three are stop codons. AUG usually serves as the start codon and specifies methionine. The code is redundant because several codons can specify one amino acid, but it is not ambiguous: each codon has one meaning in a given code. The code is nearly universal, with important mitochondrial variations. A reading frame is established by the start site and must be maintained; insertion or deletion of a number of bases not divisible by three causes a frameshift and changes all downstream codons. Mutation effect Meaning Likely consequence Synonymous Codon changes but amino acid remains the same. Often mild, but may affect splicing, mRNA stability or translation speed. Missense One amino acid is replaced. Effect depends on residue, domain, conservation and protein function. Nonsense Codon becomes a premature stop. Truncated protein or nonsense-mediated mRNA decay. Frameshift Insertion/deletion alters triplet grouping. Abnormal downstream sequence and often premature termination. Splice-altering Changes exon–intron processing. Exon skipping, intron retention or abnormal transcript. 2. Translation Initiation assembles the ribosome at the start codon; elongation cycles through codon recognition, peptide-bond formation and translocation; termination occurs when a stop codon recruits release factors. Transfer RNA anticodons pair with mRNA codons and deliver amino acids. Ribosomes may attach to the rough endoplasmic reticulum when the nascent protein has a signal peptide. Translation is regulated by nutrient status, stress responses, microRNAs and initiation-factor phosphorylation. A transcript can be present but poorly translated, so RNA abundance alone does not always predict protein abundance or clinical effect. 3. Promoters and transcription initiation A promoter contains DNA elements where general transcription factors and RNA polymerase assemble. Core promoter motifs vary by gene. Cell-specific transcription factors bind nearby regulatory sequences and recruit co-activators, chromatin remodelers or co-repressors. A promoter variant may reduce transcription without changing the coding sequence. 4. Enhancers, silencers and insulators Enhancers can act thousands of bases away and often work through DNA looping to contact a promoter. Silencers reduce transcription through repressor proteins and chromatin compaction. Insulators and boundary elements prevent an enhancer from activating the wrong neighbouring gene. Structural variants can move an enhancer next to a different gene and cause disease through “enhancer hijacking.” 5. Epigenetic regulation DNA methylation at many promoter CpG sites is associated with reduced transcription, although context matters. Histone acetylation usually opens chromatin, while selected histone methylation marks can activate or repress. Nucleosome positioning controls access for polymerases and transcription factors. Epigenetic states are heritable through cell division but can be altered by development, inflammation, nutrition and drugs. 6. Regulation after transcription Alternative splicing creates different mRNAs from one gene. RNA editing changes selected bases; poly-A length affects stability; RNA-binding proteins control transport and degradation; and microRNAs guide repression or transcript destruction. These layers allow rapid adaptation and tissue-specific expression. 7. Prokaryotic operons In bacteria, related genes may be transcribed as one polycistronic mRNA. The lac operon is induced when lactose is available and glucose is low: the repressor is removed by allolactose and CAP–cAMP helps recruit polymerase. The trp operon is repressed when tryptophan is abundant and can use attenuation to sense translation. Operons provide efficient metabolic control. 8. Eukaryotic gene control Eukaryotes separate transcription in the nucleus from translation in the cytoplasm and use chromatin, enhancers, promoter choice, RNA processing, transport, translation and protein degradation. A signal such as a steroid hormone can bind an intracellular receptor that acts as a transcription factor. Growth-factor receptors activate kinase cascades that ultimately modify nuclear transcription factors. 9. Cell signalling and gene regulation Ligand binding to a receptor can activate second messengers, protein kinases and transcription factors. The MAPK pathway often supports proliferation; JAK–STAT transmits cytokine signals; NF-kB responds to inflammation; and TGF-beta regulates differentiation and extracellular matrix. Mutations that activate signalling independently of a ligand can produce cancer or developmental disease. 10. Regulation in development and differentiation Cells remember their identity through stable combinations of transcription factors and epigenetic marks. Master regulators activate networks rather than single traits. During development, a transient signal can establish a self-reinforcing programme; later, chromatin changes maintain the state. Errors can cause congenital malformations, failed differentiation or malignancy. 11. When regulation goes wrong Promoter silencing Methylation can reduce expression of a tumour suppressor or produce imprinting-related disease. Enhancer disruption Deletion or translocation can separate a gene from its normal regulatory landscape. Splicing failure Variants or altered splicing factors generate abnormal transcripts and proteins. Abnormal signalling Constitutive kinase or transcription-factor activity drives proliferation, inflammation or fibrosis. 12. Clinical interpretation When a variant lies outside a coding exon, ask whether it could affect promoter, enhancer, splice, untranslated-region or chromatin function. RNA studies can demonstrate aberrant splicing; methylation assays can assess imprinting or epigenetic silencing; chromatin and expression studies may support regulatory mechanisms. The absence of a coding mutation does not exclude a regulatory disorder. Do not assume “non-coding” means “non-functional.” Regulatory DNA, untranslated regions and non-coding RNAs can be essential to the timing, tissue specificity and amount of gene expression. 13. Examination summary The genetic code determines how mRNA triplets specify protein, while gene regulation decides when and where that code is used. Promoters initiate transcription; enhancers and silencers tune it; chromatin and epigenetic marks control access; RNA processing and degradation adjust transcripts; translation and protein turnover complete the control system. Disease can result from coding variants, regulatory disruption, abnormal splicing or pathway misactivation. References SlideShare: Genetic Code. SlideShare: Gene Regulation. OpenStax: Regulation of Gene

Gene Structure and Function: From DNA Sequence to Clinical Phenotype

Gene Structure and Function A gene is not simply “a piece of DNA.” A typical human protein-coding gene is an organised sequence of regulatory and transcribed regions arranged along DNA. Its structure determines where transcription begins, which RNA is produced, how that RNA is processed, where translation begins and ends, and how much functional protein is made. Understanding this arrangement is the foundation for interpreting variants and explaining inherited disease. The central idea: DNA regulatory information controls transcription; the primary RNA transcript is processed into mature mRNA; the mRNA is translated into a polypeptide; and the polypeptide is folded, modified, transported and regulated to produce a phenotype. The gene map: read it from 5′ to 3′ A typical eukaryotic protein-coding gene 5′ side of DNA Region in order What it controls or produces Upstream Enhancers and silencers How strongly, where and when the gene is expressed Upstream Promoter and transcription-start site Recruitment of transcription factors and RNA polymerase II; beginning of RNA synthesis Transcribed 5′ untranslated region mRNA stability and efficiency of ribosome recruitment Translated Start codon Defines the beginning of the open reading frame Translated Coding exons separated by introns in the primary transcript Sequence that determines the amino-acid order after splicing Translated Stop codon Signals termination of translation Transcribed 3′ untranslated region mRNA stability, localisation and post-transcriptional regulation Downstream Polyadenylation and termination region Cleavage, poly-A addition and termination of transcription Important: the DNA gene contains exons and introns, but the mature mRNA does not normally contain the introns. The “coding sequence” is only the part translated into amino acids; the whole gene is larger because it also includes regulatory and untranslated regions. 1. DNA is the physical information store DNA is a double helix made from two antiparallel nucleotide strands. Each nucleotide contains phosphate, deoxyribose sugar and a nitrogenous base. Complementary pairing—A with T and C with G—allows information to be copied and repaired. The order of bases, not merely the amount of DNA, carries the instruction. A chromosome contains one long DNA molecule packaged around histone proteins. A locus is the physical position of a gene. An allele is one version of a gene. A genome includes coding genes, regulatory sequences, non-coding RNA genes, repetitive DNA, centromeres and telomeres. Therefore, a gene must be understood within chromatin and chromosome organisation. Clinical connection When a laboratory reports a variant, the doctor must ask: Which gene? Which transcript? Which genomic position? Which allele? Is it coding, regulatory or splice-related? What is the zygosity? How does it fit the phenotype and family history? 2. Regulatory DNA: deciding when a gene is used Enhancers An enhancer is a regulatory DNA element that can increase transcription when activator proteins bind to it. Enhancers may lie thousands of bases away, upstream, downstream or within an intron. DNA looping brings the enhancer-bound proteins into contact with the promoter through mediator and chromatin-associated proteins. Silencers and repressors Silencers reduce transcription when repressor proteins bind. Repressors may block transcription-factor binding, recruit enzymes that compact chromatin, or interfere with mediator and RNA polymerase. A pathogenic regulatory variant can therefore lower gene expression even though every coding exon is normal. Insulators and boundaries Insulators help separate neighbouring regulatory domains. They prevent an enhancer from activating the wrong promoter and help maintain tissue-specific expression. Disruption of a boundary can cause a normal gene to be expressed in the wrong place or at the wrong time. Do not call non-coding DNA “junk” automatically. A promoter, enhancer, silencer, splice element or untranslated region can be clinically important even when it does not encode amino acids. 3. The promoter and transcription-start site The promoter is the landing and assembly region for transcription. General transcription factors recognise promoter features and position RNA polymerase II. The transcription-start site is the nucleotide at which the initial RNA transcript begins. The promoter is not the same as the start codon: transcription can begin before translation begins. Promoter activity is tissue-specific. A liver cell, neuron and erythroid cell may use different transcription factors on the same genome. Promoter methylation or a promoter sequence variant can prevent the correct amount of RNA from being produced. 4. The 5′ untranslated region and start codon The first part of the transcript is the 5′ UTR. It is transcribed into RNA but not translated into protein. It can contain secondary structures and regulatory signals that affect ribosome scanning, translation initiation and mRNA stability. The start codon, usually AUG in mRNA, establishes the reading frame for the open reading frame. A mutation before the start codon may reduce translation. A new upstream start codon may divert the ribosome. A change in the start codon may abolish normal initiation or cause use of an alternative start site, producing a shortened or abnormal protein. 5. Exons: what remains in mature mRNA Exons are the segments retained after RNA splicing. Some exon sequence is untranslated, while coding exons contribute codons to the protein. Exons may encode catalytic domains, membrane-spanning regions, signal peptides, ligand-binding sites or protein-interaction domains. Exon boundaries matter because a variant can remove an entire exon, change the reading frame or alter a domain. Alternative exon choice also allows one gene to make different proteins in different tissues. 6. Introns: removed sequences with important functions Introns are transcribed into the initial pre-mRNA but removed during splicing. They are not simply useless gaps. Introns can contain enhancers, regulatory sequences, non-coding RNA genes and alternative exons. Their length and sequence can affect transcription and splicing efficiency. Splicing depends on the 5′ donor site, branch point, polypyrimidine tract and 3′ acceptor site. A variant near any of these signals may cause exon skipping, intron retention or activation of a cryptic splice site. The mature mRNA may then encode an abnormal protein or be destroyed by nonsense-mediated decay. How a splice variant causes disease DNA change weakens the normal splice signal. The spliceosome chooses an abnormal site. An exon is skipped or intronic sequence is retained. The reading frame may shift or a premature stop may